子宫内膜癌宫颈间质浸润的预后与临床意义:一项多中心回顾性研究
这项多中心回顾性研究纳入2000至2019年中国9家区域医疗机构收治的2009年国际妇产科联盟I至II期子宫内膜癌手术分期患者共7383例,其中宫颈间质浸润524例、无宫颈间质浸润6859例。多变量分析显示宫颈间质浸润与无进展生存期(校正HR 1.31,95%CI 0.94-1.81,P=.106)和总生存期(校正HR 1.33,95%CI 0.88-2.00,P=.171)无独立关联;倾向评分匹配后两组5年无进展生存率与总生存率相似。
要点
- 宫颈间质浸润与无进展生存期无独立关联(校正HR 1.31,95%CI 0.94-1.81,P=.106)。
- 宫颈间质浸润与总生存期无独立关联(校正HR 1.33,95%CI 0.88-2.00,P=.171)。
- 倾向评分匹配后两组5年无进展生存率与总生存率相似。
核心结论
- 校正混杂因素后,宫颈间质浸润不影响2009年国际妇产科联盟I至II期子宫内膜癌女性的无进展生存期或总生存期。
研究设计与样本
- 多中心回顾性研究,纳入2000至2019年中国9家区域医疗机构收治的2009年国际妇产科联盟I至II期子宫内膜癌手术分期患者共7383例,其中宫颈间质浸润524例、无宫颈间质浸润6859例。
- 主要结局为无进展生存期,次要结局为总生存期;采用Cox比例风险回归模型估计风险比及95%置信区间,并应用倾向评分匹配平衡基线特征。
主要发现
- 全队列多变量分析中,宫颈间质浸润与无进展生存期无独立关联(校正HR 1.31,95%CI 0.94-1.81,P=.106)。
- 全队列多变量分析中,宫颈间质浸润与总生存期无独立关联(校正HR 1.33,95%CI 0.88-2.00,P=.171)。
- 倾向评分匹配队列中,有与无宫颈间质浸润患者5年无进展生存率相似(92.3% vs 93.7%,P=.493),5年总生存率相似(95.0% vs 95.7%,P=.791)。
- 按组织学类型和辅助治疗进行的亚组分析亦显示有与无宫颈间质浸润患者生存结局无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometrial cancers that invade the cervical stroma are generally associated with worse clinical outcomes than tumors confined to the uterine corpus. However, tumors that spread to the cervical stroma often present other adverse prognostic features, making it uncertain whether cervical stromal invasion independently influences prognosis. Previous studies have provided limited and inconsistent results. OBJECTIVE: The objective of this study was to evaluate the independent prognostic significance of cervical stromal invasion in patients with early-stage endometrial cancer. STUDY DESIGN: This multicenter retrospective study included patients with International Federation of Gynecology and Obstetrics 2009 stage I to II endometrial cancer who underwent surgical staging at 9 regional medical institutions across China between 2000 and 2019. The primary outcome was progression-free survival, and the secondary outcome was overall survival. Cox proportional hazards regression models were used to estimate hazard ratios and 95% confidence intervals for the association of cervical stromal invasion with survival outcomes. Propensity score matching was applied to balance baseline characteristics between patients with and without cervical stromal invasion. Variables used for propensity score were age at diagnosis, hypertension, diabetes, carbohydrate antigen 125 level, histological type, depth of myometrial invasion, lymphovascular space invasion, peritoneal cytology, surgical approach, type of hysterectomy, lymphadenectomy, and adjuvant therapy. To assess the robustness of the findings, subgroup analyses were performed. RESULTS: A total of 7383 patients were included (524 with cervical stromal invasion and 6859 without cervical stromal invasion). Cervical stromal invasion was not independently associated with decreased progression-free survival (adjusted hazard ratio, 1.31; 95% confidence interval, 0.94-1.81; P=.106) and overall survival (adjusted hazard ratio, 1.33; 95% confidence interval, 0.88-2.00; P=.171) at multivariable analysis performed on the entire cohort. In the propensity score-matched cohort, patients with and without cervical stromal invasion showed similar 5-year progression-free survival and overall survival (92.3% vs 93.7%, P=.493; 95.0% vs 95.7%, P=.791). Subgroup analyses by histological type and adjuvant therapy also showed no differences in survival outcomes between patients with and without cervical stromal invasion. CONCLUSION: After adjusting for confounders, the presence of cervical stromal invasion does not affect progression-free survival or overall survival in women with International Federation of Gynecology and Obstetrics 2009 stage I to II endometrial cancer.
引用
- Li Z, Yang Y, Fang Y, et al. The prognostic and clinical significance of cervical stromal invasion in endometrial cancer: a multicenter retrospective study. Am J Obstet Gynecol. 2025. PMID: 41421746. doi:10.1016/j.ajog.2025.12.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。